Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

In addition to Wegovy, incretin mimetics FDA-approved for ... Research and Manufacturers of America, condemned the ad for misleading consumers about the safety and effectiveness of the compounded ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Although not explicitly stated, a viewer might surmise that the company offers effective weight-loss medicines at a substantially lower price than brand-name drugs like Wegovy and Ozempic. The ad ...

Novo Nordisk, the Fortune 500 Europe company behind weight-loss injection Wegovy (semaglutide), responded Monday with a print ad of its own. “Do you really know what you’re injecting into your body?” ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.